Abstract
In inflammatory, infectious, ischemic, and neurodegenerative pathologies of th central nervous system (CNS) glia become “activated” by inflammatory mediators, and express new proteins such as the inducible isoform of nitric oxide synthase (iNOS). Although these activated glia have beneficial roles, in vitro they potently kill cocultured neurons, and there is increasing evidence that they contribute to pathology in vivo. Nitric oxide (NO) from iNOS appears to be a key mediator of such glial-induced neuronal death. The high sensitivity of neurons to NO is partly due to NO causing inhibition of respiration, rapid glutamate release from both astrocytes and neurons, and subsequent excitotoxic death of the neurons. NO is a potent inhibitor of mitochondrial respiration, due to reversible binding of NO to cytochrome oxidase in competition with oxygen, resulting in inhibition of energy production and sensitization to hypoxia. Activated astrocytes or microglia cause a potent inhibition of respiration in cocultured neurons due to glial NO inhibiting cytochrome oxidase within the neurons, resulting in ATP depletion and glutamate release. In some conditions, glutamate-induced neuronal death can itself be mediated by N-methyl-d-aspartate (NMDA)-receptor activation of the neuronal isoform of NO synthase (nNOS) causing mitochondrial damage. In addition NO can be converted to a number of reactive derivatives such as peroxynitrite, NO2, N2O3, and S-nitrosothiols that can kill cells in part by inhibiting mitochondrial respiration or activation of mitochondrial permeability transition, triggering neuronal apoptosis or necrosis.
Similar content being viewed by others
References
Eddleston M. and Mucke L. (1993) Molecular profile of reactive astrocytes—implications for their role in neurologic disease. Neurosci. 54, 15–36.
Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. TINS 19, 312–318.
Kyrkanides S., O’Banion M. K., Whiteley P. E., Daeschner J. C., and Olschowka J. A. (2001) Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury. J. Neuroimmunol. 119, 269–277.
Piehl F. and Lidman O. (2001) Neuroinflammation in the rat CNS cells and their role in the regulation of immune reactions. Immunol. Rev. 184, 212–225.
Dong Y., Benveniste E. N. (2001) Immune function of astrocytes. Glia 36, 180–190.
Acarin L., Gonzalez B., and Castellano B. (2001) Glial activation in the immature rat brain: implication of inflammatory transcription factors and cytokine expression. Prog. Brain. Res. 132, 375–89.
Banati R. B., Gehramann J., Schubert P., and Kreutzberg G. W. (1993) Cytotoxicity of microglia. Glia 7, 111–118.
Hewett S. J., Csernansky C. A., and Choi D. W. (1994) Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13, 487–494.
Bolanos J. P., Almeida A., Stewart V., Peuchen S., Land J. M., Clark J. B., and Heales S.J.R. (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68, 2227–2240.
Chao C. C. (1996) Cytokine-stimulated astrocytes damage human neurons via a NO mechanism. Glia 16, 276–284.
Hu J., Ferreira A., and Van Eldik L. J. (1997) S100 beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69, 2294–2301.
Kingham P. J., Cuzner M. L., and Pocock J. M. (1999) Apoptotic pathways mobilized in microglia and neurons as a consequence of chromogranin A-induced microglial activation. J. Neurochem. 73, 538–547.
Tanabe K., Akanishi H., Maeda H., Nishioku T., Hashimoto K., Liou S. Y., Akamines A., and Yamamoto K. (1999) A predominant apoptotic death pathway of neuronal PC12 cells induced by activated microglia is displaced by a nonapoptotic death pathway following blocakage of caspase-3-dependent cascade. J. Biol. Chem. 274, 15,725–15,731.
Loihl A. K. and Murphy S. (1998) Expression of NOS-2 in glia associated with CNS pathology. Prog. Brain Res. 118, 253–267.
Bolanos J. P. and Almeida A. (1999) Role of nitric oxide in brain hypoxia-ischaemia. Biochim. Biophys. Acta 1411, 415–436.
Liberatore G. T., Jackson-Lewis V., Vukosavic S., et al. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Medicine 5, 1403–1409.
Itagaki S., McGeer P. L., Akiyama H., Zhu S., and Selkoe D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer Disease. J. Neuroimmunol. 24, 173–182.
Miyazono M., Iwaki T., Kitamoto T., Kaneko Y., Doh-ura K., and Tateishi J. (1991) A comparative immunohistochemical study of Kuru and senile plaques with aspecial reference to glial reactions at various stages of amyloid plaque formation. Am. J. Pathol. 139, 589–598.
McGeer P. L. and Rogers J. (1992) Antiinflammatory agents as a therapeutic approach to Alzheimer’s disease. Neurology 42, 447–449.
Wa J., Food M. R, Gabathuler R., Rothenberger S., Yamada T., Yasuhara O., and McGeer P. L. (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer’s disease brain tissue express melanotransferrin. Brain Res. 712, 122–126.
Wallace M. N., Geddes J. G., Farquhar D. A., and Masson M. R. (1997) Nitic oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp. Neurol. 144, 266–272.
Lee S. C., Zhao M. L., Hirano A., and Dickson D. W. (1999) Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. J. Neuropathol. Exp. Neurol. 58, 1163–1169.
Meda L., Cassatella M. A., Szendrei G. I., et al. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647–650.
Goodwin J., Uemura E., and Cunnick J. E. (1995) Microglial release of nitric oxide by the synergistic action of beta-amyloid, and IFN-gamma. Brain Res. 692, 207–214.
Ishii K., Muelhauser F., Liebl U., et al. (2000) Subacute NO generation induced by Alzheimer’s beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase. FASEB J. 14, 1485–1489.
McGeer E. G. and McGeer P. L. (1995) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharm. Des. 10, 821–836.
McGeer P. L., Schulzer M., and McGeer E. G. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47, 425–432.
Lim G. P, Yang F., Chu T., et al. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer’s disease. J. Neurosci. 20, 5709–5714.
Ruffolo R. R., Feuerstein G. Z., Hunter A. J., Poste G., and Metcalf B. W., Eds. (1999) Inflammatory cells and mediators in CNS diseases. Eds., Harwood Academic Publishers.
Hart M. N. and Fabry Z. (1995) CNS antigen presentation. Trends Neurosci. 11, 475–481.
Hickey W. F., Hsu B. L., and Kimura H. (1991) T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254–260.
Allan S. M. and Rothwell N. J. (2001) Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734–744.
Beckman J. S., Chen J., Crow J. P., and Ye Y. Z. (1994) Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeration. Progress in Brain. Res. 103, 371–380.
Chao C. C., Hu S., and Peterson P. K. (1995) Modulation of human microglial cell superoxide production by cytokines. J. Leukoc. Biol. 58, 65–70.
Chao C. C., Hu S., Sheng W. S., Kravitz F. H., and Peterson P. P. (1999) Inflammation-mediated neuronal cell injury. In: Inflammatory Cells and Mediators in CNS diseases (Ruffolo R. R., Feuerstein G. Z., Hunter A. J., Poste G., and Metcalf B. W., eds.) Harwood Academic Publishers, pp. 483–495.
Piani D., Frei K., Do K. Q., Cuenod M., and Fontana A. (1991) Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159–162.
Piani D., Spranger M., Frei K., Schaffner A., and Fontana A. (1992) Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22, 2429–2436.
Barger S. W. and Basile A. S. (2001) Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76, 846–854.
Chao C. C., Hu S., Ehrlich L., and Peterson P. K. (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain. Behav. Immun. 9, 355–365.
Viviani B., Corsini E., Galli C. L., and Marinovich M. (1998) Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol. Appl. Pharmacol. 150, 271–276.
Heales S.J.R., Bolanos J. P., Stewart V. C., Brookes P. S., Land J. M., and Clark J. B. (1999) Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta. 1410, 215–228.
Brown G. C., Bolanos J. P., Heals S. J., and Clark J. B. (1995) Nitric-oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193, 201–204.
Murphy S. (2000) Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29, 1–14.
McNaught K.S.P. and Brown G. C. (1998) Nitric oxide causes glutamate release from brain synaptosomes following inhibition of mitochondrial function. J. Neurochem. 70, 1541–1546.
Bal-Price A. and Brown G. C. (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal repiration, causing glutamate release and excitotoxicity. J. Neurosci. 21, 6480–6491.
Trabace L. and Kendrick K. M. (2000) Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J. Neurochem. 75, 1664–1674.
Bal-Price A., Moneer Z., and Brown G. C. (2002) Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40, 312–323.
Bal-Price A., Matthias A., and Brown G. C. (2002) Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J. Neurochem. 80, 73–80.
Torreilles F., Salman-Tabcheh S., Guerin M., and Torreilles H. (1999) Neurodegenerative disorders: the role of peroxynitrite. Brain. Res. Rev. 30, 153–163.
Dawson V. L., and Dawson T. M. (1996) Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10, 179–190.
Radi R., Cassina A., and Hodara R. (2002) Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem. 383, 401–409.
Gunasekar P. G., Kanthasamy A. G, Borowitz J. L., and Isom G. E. (1995) NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J. Neurochem. 65, 2016–2021.
Stewart V. C., Heslegrave A. J., Brown G. C., Clark J. B., and Heales S. J. (2002) Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor. Eur. J. Neurosci. 15, 458–464.
Prast K. and Philippu A. (2000) Nitric oxide as modulator of neuronal function. Progress in Neurobiol. 64, 51–68.
Serou M. J., DeCoster M. A., and Bazan N. G. (1999) Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J. Neurosci. Res. 58, 593–598.
Possel H., Noack H., Putzke J., Wolf G., and Sies H. (2000) Selective upregulation of inducible nitric oxide synthase (iNOS by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 32, 51–59.
Simmons M. L. and Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897–905.
Tran M. H., Yamada K., Olariu A., Mizuno M., Ren X. H., and Nabeshima T. (2001) Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB 15, 1407–1409.
Taylor B. S. and Geller D. A. (2000) Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13, 413–424.
Lee S. C. and Brosnan C. F. (1996) Cytokine Regulation of iNOS Expression in Human. Glial Cells Methods 10, 31–37.
Merrill J. E., Murphy S. P., Mitrovic B., et al. (1997) Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J. Neurosci. Res. 48, 372–384.
Wagner A. H., Schwabe O., and Hecker M. (2002) Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ. Br. J. Pharmacol. 136, 143–149.
Skaper S. D., Facci L., and Leon A. (1995) Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64, 266–276.
Fukuto J. M., Cho J. Y., and Switzer C. H. (2000) The chemical properties of nitric oxide and related nitrogen oxides. In: Nitric Oxide Biology and Pathology (Ignarro L., ed.) Academic Press, USA, pp. 23–40.
Nicholls D. G. and Budd S. L. (2000) Mitochondria and neuronal survival. Physiol. Rev. 80, 315–360.
Manfredi G. and Beal M. F. (2000) The role of mitochondria in the pathogenesis of neurodegenerative diseases. Brain. Pathol. 10, 462–472.
Bolanos J. P., Peuchen S., Heales S. J., Land J. M., and Clark J. B. (1994) Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63, 910–916.
Bolanos J. P., Heales S. J., Land J. M., and Clark J. B. (1995) Effect of peroxy-nitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64, 1965–1972.
Brown G. C. and Borutaite V. (2002) Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Rad. Biol. Med. 33, 1440–1450.
Brown G. C. (2001) Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta. 1504, 46–57.
Stewart V. C., Land J. M., Clark J. B., and Heales S. J. (1998) Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage. J. Neurochem. 70, 432–434.
Stewart V. C., Sharpe M. A., Clark J. B., and Heales S. J. (2000) Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J. Neurochem. 75, 694–700.
Brown G. C. and Cooper C. E. (1994) Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 345, 50–54.
Cleeter M. W. J., Cooper J. M., Darley-Usmar V. M., Moncada S., and Schapira A.H.V. (1994) Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respirator chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345, 50–54.
Cooper C. E. (2002) Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector? Trends Biochem Sci. 27, 33–39.
Brorson J. R., Schumacker P. T., and Zhang H. (1999) Nitric oxide acutely inhibits neuronal energy production. J. Neurosci. 19, 147–158.
Almeida A., Almeida J., Bolanos J. P., and Moncada S. (2001) Different responses of astrocytes and neurons to nitric oxide. The role of glycolytically generated ATP in astrocyte protection. Proc. Natl. Acad. Sci. 98, 15,294–15,249.
Lee V. Y., McClintock D. S., Santore M. T., Budinger G.R.S., and Chandel N. S. (2002) Hypoxia sensitizes cells to nitric oxide-induced apoptosis. J. Biol. Chem. 277, 16,067–16,074.
Brown G. C., Foxwell N., and Moncada S. (1998) Transcellular regulation of cell respiration by NO generated by activated macrophages. FEBS Lett. 439, 321–324.
Borutaite V., Matthias A., Harris H., Moncada S., and Brown G. C. (2001) Reversible inhibition of cellular respiration by nitric oxide in vascular inflammation. Am. J. Physiol. 24, 2256–2260.
Cassina A. and Radi R. (1996) Different inhibitory actions of NO and peroxy-nitrite on mitochondrial electron transport. Arch. Biophys. Biochem. 328, 309–316.
Clementi E., Brown G. C., Feelisch M., and Moncada S. (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective role of glutathione. Proc. Natl. Acad. Sci. USA 95, 7631–7636.
Ribo N. A., Clementi E., Melani M., Boveris A., Cadenas E., Moncada S., and Poderoso J. I. (2001) Nitric oxide inhibits mitochondrial NADH: ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 359, 139–145.
Borutaite V., Budriunaite A., and Brown G. C. (2000) Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim. Biophys. Acta. 1459, 405–412.
Drapier J. C. and Hibbs J. B., Jr. (1988) Differentiation of murine macrophages to express non-specific cytotoxicity for tumour cells results in l-arginine-dependent inhibition of mitochondrial iron-sulphur in the macrophage effector cells. J. Immunol. 140, 2829–2838.
Stuehr D. J. and Nathan C. F. (1989) NO: a macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J. Exp. Med. 169, 1543–1555.
Yamamoto T., Maruyama W., Kato Y., Yi H., Shamoto-Nagai M., Tanaka M., Sato Y., and Naoi M. (2002) Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J. Neural. Transm. 109, 1–13.
Henry Y., Lepoivre M., Drapier J. C., Ducrocq C., Boucher J. L., and Guissani A. (1993) EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7, 1124–1134.
Welter R., Yu L., and Yu C. A. (1996) The effects of nitric oxide on electron transport complexes. Arch. Biochem. Biophys. 331, 9–14.
Stachowiak O., Dolder M., Wallimann T., and Richter C. (1998) Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 273, 16,694–16,699.
Gadelha F. R., Thomson L., Fagian M. M., Costa A.D.T., Radi R., and Vercesi A. E. (1997) Calcium-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch. Biochem. Biophys. 345, 243–250.
Liu Z. and Martin L. J. (2001) Motor neurons rapidly accumulate DNA single-strand breaks after in vitro exposure to nitric oxide and peroxynitrite and in vivo axotomy. J. Comp. Neurol. 432, 35–60.
Sharpe M. A. and Cooper C. E. (1998) Interaction of peroxynitrite with mitochondrial cytochrome oxidase: catalytic production of nitric oxide and irreversible inhibition of enzyme activity. J. Biol. Chem. 273, 30,961–30,972.
Cooper C. E. and Davies N. A. (2000) Effects of nitric oxide on the cytochrome oxidase Km for oxygen: implications for mitochondrial pathology. Biochim. Biophys. Acta. 1459, 390–396.
Packer M. A. and Murphy M. P. (1994) Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett. 345, 237–240.
Borutaite V., Morkuniene R., and Brown G. C. (1999) Release of cytochrome c from heart mitochondria is induced by high calcium and peroxynitrite and is responsible for calciuminduced inhibition of substrate oxidation. Biochim. Biophys. Acta. 1453, 41–48.
Borutaite V., Morkuniene R., and Brown G. C. (2000) Nitric oxide donors, nitrosothiols and mitochondrial respiration inhibitors induce caspase activation by different mechanisms. FEBS Lett. 467, 155–159.
Bernardi P., Petronilli V., Di Lisa F., and Forte M. (2001) A mitochondrial perspective on cell death. Trends Biochem. Sci. 26, 112–117.
Crompton M. (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341, 233–249.
Brookes P. S., Salinas E. P., Darley-Usmar K., Eiserich J. P., Freeman B. A., Darley-Usmar V. D., and Anderson P. G. (2000) Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem. 275, 20,474–20,479.
Viveira H. L., Belzacq A. S., Haouzi D., et al. (2001) The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305–4316.
Piantadosi C. A., Tatro L. G., and Whorton A. R. (2002) NO and differential effects of ATP on mitochondrial permeability transition. Nitric Oxide 6, 45–60.
Daugas E., Nochy D., Ravagnan L., Loeffler M., Susin S. A., Zamzami N., and Kroemer G. (2000) Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 476, 181–123.
Chai J., Du C., Wu J. W., Kyin S., Wang X., and Shi Y. (2000) Structural and biochemical basis of apoptotic activation by Smac/Diablo. Nature 406, 855–862.
Petronilli V., Penzo D., Scorrano L., Bernardi P., and Di Lisa F. (2001) The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J. Biol. Chem. 276, 12,030–12,034.
Folbergrova J., Li P. A., Uchino H., Smith M. L., and Siesjo B. K. (1997) Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp. Brain. Res. 114, 44–50.
Zhu S., Stavrovskaya I. G., Drozda M., et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74–78.
Sankarapandi S., Zweier J. L., Mukherjee G., Quinn M. T., and Huso D. L. (1998) Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys. 353, 312–321.
McBride A. and Brown G. C. (1997) Activated human neutrophils rapidly break down nitric oxide. FEBS Lett. 417, 231–234.
Do K. Q., Grima G., Benz B., and Salt T. E. (2002) Glial-neuronal transfer of arginine and s-nitrosothiols in NO transmission. Ann. NY Acad. Sci. 962, 81–92.
Yoneyama H., Yamamoto A., and Kosaka H. (2001) Neuronal nitric oxide synthase generates superoxide from the oxygenase domain. Biochem. J. 360, 247–253.
Xia Y. and Zweier J. L. (1997) Superoxide and peroxynitrite generation from inducible NO synthase in macrophages. Proc. Natl. Acad. Sci. USA 94, 6954–6958.
McBride A., Borutaite V., and Brown G. C. (1999) Superoxide dismutase and hydrogen peroxide cause rapid nitric oxide breakdown, peroxynitrite production and subsequent cell death. Biochim. Biophys. Acta 1454, 275–288.
Bauer G. (2000) Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis. Anticancer Res. 20, 4115–4139.
Brown G. C. (1995) Reversible binding and inhibition of catalase by nitric oxide. Eur. J. Biochem. 232, 188–191.
Boveris A. and Cadenas E. (2000) Mitochondrial production of hydrogen peroxide regulation by NO and the role of ubisemiquinone. IUBMB Life 50, 245–250.
Wei T., Chen C., Hou J., Xin W., and Mori A. (2000) Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim. Biophys. Acta. 1498, 72–79.
Eliasson M. J., Huang Z., Ferrante R. J., Sasamata M., Molliver M. E., Snyder S. H., and Moskowitz M. A. (1999) Neuronal NO synthase activation and peroxynitrite formation in bschemic stroke linked to neural damage. J. Neurosci. 19, 5910–5918.
Lipton S. A., Choi Y. B., Pan Z. H., et al. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of NO and related nitroso-compounds. Nature 364, 626–632.
Skaper S. D., Facci L., and Leon A. (1995) Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64, 266–276.
Xie Z., Wei M., Morgan T. E., Fabrizio P., Han D., Finch C. E., and Longo V. D. (2002) Peroxynitrite mediates neurotoxicity of amyloid beta-peptidel-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22, 3484–3492.
Zhang J., Dawson V., Dawson T., and Synder S. (1994) Nitric oxide activation of poly(ADP-ribose)synthase and neurotoxicity. Science 263, 687–684.
Di Stasi A. M., Mallozzi C., Macchia G., Maura G., Petrucci T. C., and Minetti M. (2002) Peroxynitrite affects exocytosis and SNARE complex formation and induces tyrosine nitration of synaptic proteins. J. Neurochem. 82, 420–429.
Leist M., Fava E., Montecucco C., and Nicotera P. (1997) Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 9, 1488–1498.
Zhang X., Chen J., Graham S. H., et al. (2002) Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82, 181–191.
Cassina P., Peluffo H., Pehar M., et al. (2002) Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J. Neurosci. Res. 67, 21–29.
Almedia A., Heales S. J., Bolanos J. P., and Medina J. M. (1998) Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790, 209–216.
Bolanos J. P., Heales S. J., Peuchen S., Barker J. E., Land J. M., and Clark J. B. (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic. Biol. Med. 21, 995–1001.
Jenner P., Dexter D. T., Sian J., Shapira A.H.V., and Marsden C. D. (1992) Oxidative stress as a cause of nigral cell death in Parkson’s disease and incidental Lewy body disease. Ann. Neurol. 32, 582–587.
Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurode-generative disease. Trends Pharmacol. Sci. 11, 379–387.
Murphy T. H., Schnaar R. L., and Coyle J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4, 1624–1633.
Schubert D. and Piasecki D. (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 21, 7455–7462.
Sattler R. and Tymianski M. (2001) Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107–129.
Schinder A. F., Olson E. C., Spitzer N. C., and Montal M. (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16, 6125–6133.
Novelli A., Reilly J. A., Lysko P. G., and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when mintracellular energy levels are reduced. Brain Res. 451, 205–212.
Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368–6371.
Strijbos P.L.M., Leach M. J., and Garthwaite J. (1996) Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J. Neuroscience. 16, 5004–5013.
Keelan J., Vergun O., and Duchen M. R. (1999) Excitotoxic mitochondrial depolarisation requires both calcium and nitric oxide in rat hippocampal neurons. J. Physiol. 520, 797–813.
Almeida A. and Bolanos J. P. (2001) A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J. Neurochem. 77, 676–690.
Ruiz F., Alvarez G., Ramos M., Hernandez M., Bogonez E., and Satrustegui J. (2000) Cyclosporin A targets involved in protection against glutamate excitotoxicity. Eur. J. Pharmacol. 404, 29–39.
Dawson V. L., Kizushi V. M., Huang P. L., Snyder S. H., and Dawson T. M. (1996) Resitance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16, 2479–2487.
Brustovetsky N. and Dubinsky J. M. (2000) Limitations of cyclosporin A inhibition of the permeability transition in CNS mitochondria. J. Neurosci. 20, 8229–8237.
Grima G., Benz B., and Do K. Q. (2001) Glialderived arginine, the NO precursor, protects neurons from NMDA-induced excitotoxicity. Eur. J. Neurosci. 14, 1762–1770.
Urushitani M., Nakamizo T., Inoue R., et al. (2001) N-methyl-d-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J. Neurosci Res. 63, 377–387.
Meffert M. K., Premack B. A., and Schulman H. (1994) Nitric oxide stimulates Ca+2-independent synaptic vesicle release. Neuron 12, 1235–1244.
Sequeira S., Ambrosio A., Malva J. O., Carvalho A. P., and Carvalho C. M. (1997) Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide. Nitric Oxide 1, 315–329.
Meffert M. K., Calakos N. C., Scheller R. H., and Schulman H. (1996) Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron 16, 1229–1236.
Piani D. and Fontana A. (1994) Involvement of the cystine transport system xc-in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 152, 3578–3585.
Noda M., Nakanishi H., and Akaike N. (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 1465–1474.
Siesjo B. K. and Bengtsson F. (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9, 127–140.
Pocock J. M. and Nicholls D. G. (1998) Exocytotic and nonexocytotic modes of glutamate release from cultured cerebellar granule cells during chemical ischaemia. J. Neurochem. 70, 806–813.
Beal M. F., Brouillet E., Jenkins B. G., et al. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181–4192.
Lee W. T., Shen Y. Z., and Chang C. (2000) Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience 95, 89–95.
Betarbet R., Sherer T. B., and Greenamyre J. T. (2002) Animal models of Parkinson’s disease. Bioessays 24, 308–318.
Greene J. G. and Greenamyre J. T. (1995) Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 2332–2338.
Greenamyre J. T., Sherer T. B., Betarbet R., and Panov A. V. (2001) Complex I and Parkinson’s disease. IUBMB Life 52, 135–141.
Kim W. K. and Ko K. H. (1998) Potentiation of N-methyl-d-aspartate-mediated neurotoxicity by immunostimulated murine microglia. J. Neurosci. Res. 54, 17–26.
Capano M., Virji S., and Crompton M. (2002) Cyclophilin-A is involved in excitotoxin-induced caspase activation in rat neuronal B50 cells. Biochem. J. 363, 29–36.
Withe B. C., Sullivan J. M., DeGracia D. J., et al. (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179, 1–33.
Leist M., Volbracht C., Kuhnle S., Fava E., Ferrandomay E., and Nicotera P. (1997) Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Molecular Medicine 11, 750–764.
Tamatami M., Ogawa S., Niitsu Y., and Tohyama M. (1998) Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis. J. Neurochem. 71, 1588–1596.
Uehara T., Kikuchi Y., and Nomura Y. (1999) Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric-oxide-induced neuronal apoptosis in SH-SY5Y cells. J. Neurochem. 72, 196–205.
Szabo C. and Dawson V. L. (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19, 287–298.
Yu S. W., Wang H., Poitras M. F., et al. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259–263.
Molina y Vedia L., McDonald B., Reep B., Brune B., Di Silvio M., Billiar T. R., and Lapentina E. G. (1992) NO-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzyme activity and increases endogenous ADP- ribosylation. J. Biol. Chem. 267, 24,929–24,932.
Albina J. E., Mastrofrancesco B., and Reichner J. S. (1999) Acyl phosphatase activity of NO-inhibited glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a potential mechanism for uncoupling glycolysis from ATP production in NO producing cells. Biochem. J. 341, 5–9.
Bal-Price A. and Brown G. C. (2000) Nitric oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J. Neurochem. 75, 1455–1464.
Leist M. and Nicotera P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239, 183–201.
Volbracht C., Fava E., Leist M., and Nicotera P. (2001) Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis. Neuroreport. 12, 3645–3648.
Leist M., Single B., Naumann H., Fava E., Simon B., Kuhnle S., and Nicotera P. (1999) Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp. Cell Res. 249, 396–403.
Ghatan S., Larner S., Kinoshita Y., Hetman M., Patel L., Xia Z., Youle R. J., and Morrison R. S. (2000) p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150, 335–547.
Cheng A., Chan S. L., Milhavet O., Wang S., and Mattson M. P. (2001) p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells. J. Biol. Chem. 276, 43,320–43,327.
Vincent A. M., TenBroeke M., and Maiese K. (1999) Neuronal intracellular pH directly mediates NO-induced programmed cell death. J. Neurobiol. 40, 171–184.
Golde S., Chandran S., Brown G. C., and Compston A. (2002) Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. J. Neurochem. 82, 269–282.
Lipton S. A. and Stamler J. S. (1994) Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33, 1229–1233.
D’Emilia D. M. and Lipton S. A. (1999) Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures. Neurosci Lett. 265, 103–106.
Torok N. J., Higuchi H., Bronk S., and Gores G. J. (2002) Nitric oxide inhibits apoptosis down-stream of cytochrome C release by nitrosylating caspase 9. Cancer Res. 62, 1648–1653.
Thippeswamy T., McKay J. S., and Morris R. (2001) Bax and caspases are inhibited by endogenous nitric oxide in dorsal root ganglion neurons in vitro. Eur. J. Neurosci. 14, 1229–1236.
Lipton S. A. (1999) Neuronal protection and destruction by NO. Cell Death Differ. 6, 943–951.
Takuma K., Phuagphong P., Lee E., Mori K., Baba A., and Matsuda T. (2001) Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 276, 48,093–48,099.
Boje K. M. and Arora P. K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587, 250–256.
Chao C. C., Hu S., Molitor T. W., Shaskan E. G., and Peterson P. K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immuno. 149, 2736–2741.
Dawson V. L., Brahmbhatt H. P., Mong J. A., and Dawson T. M. (1994) Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 33, 1425–1430.
Jeohn G. H., Kim W. G., and Hong J. S. (2000) Time dependency of the action of nitric oxide in lipopolysaccharide-interferon-gamma-induced neuronal cell death in murine primary neuronglia co-cultures. Brain Res. 880, 173–177.
Le W., Rowe D., Xie W., Ortiz I., He Y., and Appel S. H. (2001) Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson’s disease. J. Neurosci. 21, 8447–8455.
McMillian M., Kong L. Y., Sawin S. M., Wilson B., Das K., Hudson P., Hong J. S., and Bing G. (1995) Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem. Biophys. Res. Commun. 215, 572–577.
Bauer J., Rauschka H., and Lassmann H. (2001) Inflammation in the nervous system: the human perspective. Glia 36, 235–243.
Chao C. C., Lokensgard J. R., Sheng W. S., Hu S., and Peterson P. K. (1997) IL-1-induced iNOS expression in human astrocytes via NF-kappaB. Neuroreport 8, 3163–3166.
Matsuoka Y., Kitamura Y., Takahashi H., Tooyama I., Kimura H., and Gebicke-Haerter P.J. (1999) Interferon-gamma plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus. Neurochem. Int. 34, 91–99.
Iravani M. M., Kashefi K., Mander P., Rose S., and Jenner P. (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110, 49–58.
Park W. S., Chang Y. S., and Lee M. (2001) N(omega)-nitro-l-arginine methyl ester (L-NAME) attenuates the acute inflammatory responses and brain injury during the early phase of experimental Escherichia coli meningitis in the newborn piglet. Neurol. Res. 23, 862–886.
Morimoto K., Murasugi T., and Oda T. (2002) Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo. Exp. Neurol. 177, 95–104.
Vodovotz Y., Lucia M. S., Flanders K. C., et al. (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer’s disease. J. Exp. Med. 184, 1425–1433.
Smith M. A., Richey P. L., Sayre L. M., Beckman J. S., and Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J. Neurosci. 17, 2653–2657.
Duda J. E., Giasson B. I., Chen Q., et al. (2000) Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am. J. Pathol. 157, 1439–1445.
McGeer P. L. and McGeer E. G. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22, 799–809.
Tran M. H., Yamada K., Olariu A., Mizuno M., Ren X. H., and Nabeshima T. (2001) Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 15, 1407–1409.
Koistinaho M., Kettunen M. I., Goldsteins G., et al. (2002) Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc. Natl. Acad. Sci. USA 99, 1610–1615.
McGeer P. L., Yasojima K., and McGeer E. G. (2001) Inflammation in Parkinson’s disease. Adv. Neurol. 86, 83–9.
Knott C., Stern G., and Wilkin G. P. (2000) Inflammatory regulators in Parkinson’s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol. Cell Neurosci. 16, 724–739.
Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., and Hirsch E. C. (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson’s disease. Neuroscience 72, 355–363.
Good P. F., Hsu A., Werner P., Perl D. P., and Olanow C. W. (1998) Protein nitration in Parkinson’s disease. J. Neuropathol. Exp. Neurol. 57, 338–342.
Barthwal M. K., Srivastava N., and Dikshit M. (2001) Role of NO in a progressive neurodegeneration model of Parkinson’s disease in the rat. Redox Rep. 6, 297–302.
Du Y., Ma Z., Lin S., et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease. Proc. Natl. Acad. Sci. USA 98, 14,669–14,674.
Schapira A. H., Mann V. M., Cooper J. M., et al. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J. Neurochem. 55, 2142–2145.
Dehmer T., Lindenau J., Haid S., Dichgans J., and Schulz J. B. (2000) Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74, 2213–2216.
Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T., and Beal M. F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2, 1017–1021.
Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine(MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. 93, 4565–4571.
Estevez A. G., Spear N., Manuel S. M., Barbeito L., Radi R., and Beckman J. S. (1998) Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog. Brain Res. 118, 269–280.
Sasaki S., Shibata N., Komori T., and Iwata M. (2000) iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci. Lett. 8, 44–48.
Phul R. K., Shaw P. J., Ince P. G., and Smith M. E. (2000) Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 259–256.
Beckman J. S., Carson M., Smith C. D., and Koppenol W. H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584–588.
Almer G., Vukosavic S., Romero N., and Przedborski S. (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415–2425.
Sasaki S., Warita H., Abe K., and Iwata M. (2001) Inducible nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity in the spinal cords of transgenic mice with a G93A mutant SOD1 gene. J. Neuropathol. Exp. Neurol. 60, 839–846.
Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., and Isobe C. (1999) Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 46, 129–131.
Trapp B. D., Peterson J., Ransohoff R. M., Rudick R., Mork S., and Bo L. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 323–325.
Liu J. S., Zhao M. L., Brosnan C. F., and Lee S. C. (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158, 2057–2066.
De Groot C. J., Ruuls S. R., Theeuwes J. W., Dijkstra C. D., and Van der Valk P. (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56, 10–20.
Bagasra O., Michaels F. H., Zheng Y. M., et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92, 12,041–12,045.
Oleszak E. L., Zaczynska E., Bhattacharjee M., Butunoi C., Legido A., and Katsetos C. D. (1998) Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin. Diagn. Lab. Immunol. 5, 438–445.
Mitrovic B., Ignarro L. J., Montestruque S., Smoll A., and Merrill J. E. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61, 575–585.
Fenyk-Melody J. E., Garrison A. E., Brunnert S. R., Weidner J. R., Shen F., Shelton B. A., and Mudgett J. S. (1998) Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160, 2940–2946.
Pozza M., Bettelli C., Aloe L., Giardino L., and Calza L. (2000) Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution. Brain Res. 855, 39–46.
Hooper D. C., Bagasra O., Marini J. C., et al. (1997) Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94, 2528–2533.
Malinski T., Bailey F., Zhang Z. G., and Chopp M. (1993) Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13, 355–358.
Jiang K., Kim S., Murphy S., Song D., and Pastuszko A. (1996) Effect of hypoxia and reoxygenation on regional activity of nitric oxide synthase in brain of newborn piglets. Neurosci Lett. 206, 199–203.
Zhang Z. G., Chopp M., Gautam S., et al. (1994) Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 654, 85–95.
Guo Y., Ward M. E., Beasjours S., Mori M., and Hussain S. N. (1997) Regulation of cerebellar nitric oxide production in response to prolonged in vivo hypoxia. J. Neurosci. Res. 49, 89–97.
Huang Z., Huang PL., Panahian N., Dalkara T., Fishman M. C., and Moskowitz M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883–1885.
Hara H., Huang P. L., Panahian N., Fishman M. C., and Moskowitz M. A. (1996) Reduced brain edema and infarction volume in mice lacking the neuronal isoform of NO synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16, 605–611.
Ste-Marie L., Hazell A. S., Bemeur C., Butterworth R., and Montgomery J. (2001) Immunohistochemical detection of inducible nitric oxide synthase, nitrotyrosine and manganese superoxide dismutase following hyperglycemic focal cerebral ischemia. Brain Res. 918, 10–19.
Holtz M. L., Craddock S. D., and Pettigrew K. (2001) Rapid expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain. Brain Res. 898, 49–60.
Parmentier-Batteur S., Bohme G. A., Lerouet D., Zhou-Ding L., Beray V., Margaill I., and Plotkine M. (2001) Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. J. Cereb. Blood Flow Metab. 21, 15–21.
Parmentier S., Bohme G. A., Lerouet D., Damour D., Stutzmann J. M., Margaill I., and Plotkine M. (1999) Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br. J. Pharmacol. 127, 546–552.
Samdani A. F., Dawson T. M., and Dawson V. L. (1997) Nitric oxide synthase in models of focal ischemia. Stroke 28, 1283–1288.
Wei G., Dawson V. L., and Zweier J. L. (1999) Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochim. Biophys. Acta. 1455, 23–34.
Grzybicki D., Moore S. A., Schelper R., Glabinski A. R., Murphy S., and Ransohoff R. M. (1998) Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta. Neuropathol. 95, 98–103.
Wada K., Chatzipanteli K., Kraydieh S, Busto R., and Dietrich W. D. (1998) Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43, 1427–1436.
Satake K., Matsuyama Y., Kamiya M., Kawakami H., Iwata H., Adachi K., and Kiuchi K. (2000) Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Mol. Brain Res. 85, 114–122.
Kyrkanides S., O’Banion M. K., Whiteley P. E., Daeschner J. C., and Olschowka J. A. (2001) Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury. J. Neuroimmunol. 119, 269–277.
Payan H., Toga M., and Berard-Badier M. (1970) The pathology of post-traumatic epilepsies. Epilepsia 11, 390–392.
Bagetta G., Paoletti A. M., Leta A., Del Duca C., Nistico R., Rotiroti D., and Corasaniti M. T. (2002) Abnormal expression of neuronal nitric oxide synthase triggers limbic seizures and hippocampal damage in rat. Biochem. Biophys. Res. Commun. 291, 255–260.
Chavko M., Xing G., and Keyser D. O. (2001) Increased sensitivity to seizures in repeated exposures to hyperbaric oxygen: role of NOS activation. Brain Res. 900, 227–233.
Van Leeuwen R., De Vries R., and Dzoljic M. R. (1995) 7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur. J. Pharmacol. 287, 211–213.
Chung H. Y., Kim H. J., Kim J. W., and Yu B. P. (2001) The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann. NY Acad. Sci. 928, 327–335.
Hilbig H., Holler J., Dinse H. R., and Bidmon H. J. (2002) In contrast to neuronal NOS-I, the inducible NOS-II expression in aging brains is modifled by enriched environmental conditions. Exp. Toxicol. Pathol. 53, 427–431.
Shin C. M., Chung Y. H., Kim M. J., Lee E. Y., Kim E. G., and Cha C. I. (2002) Age-related changes in the distribution of nitrotyrosine in the cerebral cortex and hippocampus of rats. Brain Res. 931, 194–199.
Uttenthal L. O., Alonso D., Fernandez A. P., et al. (1998) Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat. Microsc. Res. Tech. 43, 75–88.
McCann S. M., Licinio J., Wong M. L., Yu W. H., Karanth S., and Rettorri V. (1998) The nitric oxide hypothesis of aging. Exp. Gerontol. 33, 813–826.
Adamson D. C., Wildemann B., Sasaki M., et al. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917–1921.
Rostasy K., Monti L., Yiannoutsos C., et al. (1999) Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activ-ation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann. Neurol. 46, 207–216.
Hu S., Ali H., Sheng W. S., Ehrlich L. C., Peterson P. K., and Chao C. C. (1999) Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: involvement of interleukin-1beta production by microglia. J. Neurosci. 19, 6468–6474.
Zhao M. L., Kim M. O., Morgello S., and Lee S. C. (2001) Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J. Neuroimmunol. 115, 182–191.
Giovannoni G., Miller R. F., Heales S. J., Land J. M., Harrison M. J., and Thompson E. J. (1998) Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction. J. Neurol. Sci. 156, 53–58.
Torre D., Ferrario G., Speranza F., Orani A., Fiori G. P., and Zeroli C. (1996) Serum concentrations of nitrite in patients with HIV-1 infection. J. Clin. Pathol. 49, 574–576.
Floyd R. A., Hensley K., Jaffery F., Maidt L., Robinson K., Pye Q., and Stewart C. (1999) Increased oxidative stress brought on by proinflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. Life Sci. 65, 1893–1899.
Hori K., Burd P. R., Furuke K., Kutza J., Weih K. A., and Clouse L. (1999) Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 93, 1843–1850.
Colton C. A. (1995) Induction of nitric oxide in cultured microglia: evidence for a cytoprotective role. Adv. Neuroimmunol. 5, 491–503.
Schoneboom B. A., Catlin K. M., Marty A. M., and Grieder F. B. (2000) Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice. J. Neuroimmunol. 109, 132–146.
Winkler F., Koedel U., Kastenbauer S., and Pfister H. W. (2001) Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J. Infect. Dis. 183, 1749–1759.
Leib S. L., Kim Y. S., Black S. M., Tureen J. H., and Tauber M. G. (1998) Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J. Infect. Dis. 177, 692–700.
Sugaya K., Chou S., Xu S. J., and McKinney M. (1998) Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin. Mol. Brain Res. 58, 1–9.
Wong B. S., Liu T., Paisley D., et al. (2001) Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: implications for doppel function. Mol. Cell. Neurosci. 17, 768–775.
Fabrizi C., Silei V., Menegazzi M., et al. (2001) The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106–126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogenactivated protein kinase. J. Biol. Chem. 276, 25,692–25,696.
Kim J. I., Ju W. K., Choi J. H., Choi E., Carp R. I., Wisniewski H. M., and Kim Y. S. (1999) Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapieinfected mice. Mol. Brain Res. 73, 17–27.
Van Everbroeck B., Dewulf E., Pals P., Lubke U., Martin J. J., and Cras P. (2002) The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging 23, 59–64.
Goyagi T., Goto S., Bhardwaj A., Dawson V. L., Hurn P. D., and Kirsch J. R. (2002) Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke 32, 1613–1620.
Kastenbauer S., Klein M., Koedel U., and Pfister H. W. (2001) Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res. 904, 208–217.
Corasaniti M. T., Melino G., Navarra M., Garaci E., Finazzi-Agro A., and Nistico G. (1995) Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration 4, 315–321.
Clark R. S., Kochanek P. M., Obrist W. D., et al. (1996) Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans. Crit. Care Med. 24, 1243–1251.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brown, G.C., Bal-Price, A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27, 325–355 (2003). https://doi.org/10.1385/MN:27:3:325
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MN:27:3:325